N

NGM Biopharmaceuticals Inc
F:0IK

Watchlist Manager
NGM Biopharmaceuticals Inc
F:0IK
Watchlist
Price: 1.41 EUR Market Closed
Market Cap: 117.7m EUR

Income Statement

Earnings Waterfall
NGM Biopharmaceuticals Inc

Revenue
251m USD
Cost of Revenue
-188.8m USD
Gross Profit
62.2m USD
Operating Expenses
-47.2m USD
Operating Income
15m USD
Other Expenses
-5.5m USD
Net Income
9.5m USD

Income Statement
NGM Biopharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2024 Jun-2025
Revenue
Interest Expense
1
0
Revenue
260
N/A
251
-3%
Gross Profit
Cost of Revenue
(196)
(189)
Gross Profit
63
N/A
62
-2%
Operating Income
Operating Expenses
(43)
(47)
Selling, General & Administrative
(20)
(26)
Research & Development
(12)
(17)
Depreciation & Amortization
(11)
(4)
Operating Income
21
N/A
15
-27%
Pre-Tax Income
Interest Income Expense
(0)
(3)
Non-Reccuring Items
(3)
(1)
Total Other Income
(1)
0
Pre-Tax Income
16
N/A
12
-28%
Net Income
Tax Provision
(5)
(2)
Income from Continuing Operations
12
10
Net Income (Common)
12
N/A
10
-19%
EPS (Diluted)
0.06
N/A
0.05
-17%